← Open Payments lookup

KERI LAZURE: Open Payments

NPI 1902864622 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,026 in 54 payments from 17 companies in 2025. Trend: 2023 $989 · 2024 $1,412 · 2025 $1,026

Food & beverage: $1,026
CompanyPaymentsAmount
Lilly USA, LLC15$187
AstraZeneca Pharmaceuticals LP7$176
Novo Nordisk Inc8$146
Astellas Pharma US Inc3$91
PFIZER INC.3$70
ABBVIE INC.3$70
Bayer Healthcare Pharmaceuticals Inc.3$52
Otsuka America Pharmaceutical, Inc.2$49
Exact Sciences Corporation2$30
Edwards Lifesciences Corporation1$24

Products named: MOUNJARO, Wegovy, Veozah, PAXLOVID, Kerendia, REXULTI, QULIPTA, UBRELVY.

Industry payments across NE — which companies pay providers there.